• calendar
  • globeParis, France

October 12-14, 2020

ABOUT CONFERENCE

ABOUT CONFERENCE
  • We welcome you and appreciate your participation at the Annual Congress On Digestive disorders and Liver Cancer and will be held during October 12-14, 2020 in Paris, France and will be organized around the theme of ” New Advances and Research in Digestive disorders and Liver Cancer” 
    ACDL 2020 will be operated by world-class experts in the field of Digestive disorders and Liver Cancer, International symposiums, B2B meetings, workshops will also be organized to discuss the specific topics in the field of Gene Expression in Liver, Clinical Digestive disorders, Neuro- Digestive disorders, Cellular and Molecular Digestive disorders and Liver Cancer, Neurogastroenterology and Motility, Liver fibrosis, Neuro gastroenterology and Motility and many more. ACDL 2020 will take place in the city of London, UK on March 24-25, 2020 with the theme of “Current trends in the field of Digestive disorders and Liver Cancer”. ACDL 2020 is designed to update health care providers practicing in Digestive disorders and Liver Cancer about new approaches to the diagnosis and management of digestive disorders and liver diseases. Faculty will present data on multiple topics including general Digestive disorders, inflammatory bowel disease, colorectal neoplasia, esophageal diseases, motility, nutrition, pancreatic biliary disorders, endoscopy, and hepatology. Digestive disorders are the study of the normal function and diseases of the esophagus, stomach, small intestine, colon and rectum, pancreas, gallbladder, bile ducts, and liver. ACDL 2020 has over 16 tracks designed to update physicians, nurse practitioners, physician assistants and other healthcare providers practicing in Digestive disorders and Liver Cancer. About new approaches to the diagnosis and management of Digestive disorders and Liver Cancer. Speakers will present data on multiple topics including general gastroenterology, inflammatory bowel disease, immunology, and bariatric surgery, gastrointestinal bleeding, disorders. 
    ACDL 2020 is considered as one of the major conferences that provides best platform for attendees to acknowledge and learn recent trends and advancements in field of Digestive disorders and Liver Cancer research and development. This stream of conference deals with the internal organs which help in digestion of the organic or inorganic food materials. Digestive disorders and Liver Cancer conferences showcase the discussion topics confronting the functioning of esophagus, pancreas, gallbladder, bile ducts, liver, stomach, small intestine, colon, and rectum. Business networking is an avenue for vendors to have network and B2B meetings with “Top scientists and colleagues” and with an effective low-cost marketing method for developing sales and opportunities and contacts, based on referrals and introductions either face-to-face at meetings and gatherings or by other contact methods such as Telephone, Email, Digital and Increasingly social and business networking websites.
     Why to attend? 
     ACDL 2020 will bring together experts like Gastroenterologists, Clinicians Gastroenterologists, Hepatologists, Psychiatrists, Medical practitioners, Care specialists, academic professionals and students from all over the world to share an interest in the genetic pathways underlying Gastroenterology disorders, techniques to identify those genetic pathways, and the use of genetics and genomics as tools to develop therapeutics. The aim of the conference is to provide a platform to academicians and practitioners from multiple disciplines to debate and deliberate on social change that is encompassed by innovation and technology. 
    Target Audience: 
    Endoscopy specialists
    Hepatologists 
    Gastro surgeons 
    Clinical researchers and scientists 
    Specialists Researchers and Scholars 
    Health care professionals doctors
    Medical and Health care Organizations
    Associations and Medical Practitioners, 
    Professors and Deans
    Students and Technicians 
     Gene Expression in Liver 
    There is a higher genetic diversity in tumor cells which holds at the gene expression level. Through knowing the gene expression level we can regulate the hepatocellular carcinoma during hepatitis viral infection. Disease progression in HBV and HCV induced can influence by both environmental factors and genetic risk factors. Nucleic acid-mediated gene therapy has been undergoing clinical trials which may result in the prevention of chronic liver diseases by regulating mechanisms of different proteins expression using miRNA overexpression and miRNA functional silencing. 
    Sub Tracks: 
    eQTL 
    microarray 
    liver 
    Mouse 
    Relevant societies:
     European Crohns and Colitis Organization Gastroenterohepatology 
     Association of Montenegro - GAM 
     The Australian and New Zealand Gastric and Oesophageal 
     Asian Pacific Association of Gastroenterology (APAGE) 
     Ukrainian Association of Endoscopy 
     Cellular and Molecular Gastroenterology and Hepatology 
    Medical doctors and basic scientists working in the field of hepatology and to contribute to the improvement of public health through a multidisciplinary approach by sharing advanced basic and clinical research results for various diseases of the liver and biliary tract. The journal presents up-to-date coverage of basic and clinical researches on molecular and cell biology, pathophysiology, epidemiology, diagnosis, and treatment of the various diseases of the liver and biliary tract, with special attention to more common liver diseases of the Asian-Pacific region such as B viral hepatitis and hepatocellular carcinoma (HCC). Idiosyncratic drug-induced liver injury (DILI) is a rare adverse drug reaction and it can lead to jaundice, liver failure, or even death. Antimicrobials and herbal and dietary supplements are among the most common therapeutic classes to cause DILI in the Western world. Liver fibrosis is the excessive accumulation of extracellular matrix proteins including collagen that occurs in most types of chronic liver diseases. 
    Sub Tracks:
    Liver fibrosis
    Fibro genesis 
    My fibroblast 
    Extracellular matrix
    Relevant societies: 
    Major Gastroenterology Societies around the Globe, 
    Gastroenterological Society of Australia, 
    European Society of Gastrointestinal Endoscopy (ESGE) , 
    European Society for Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN). 
     Hepato Cardiac and Pulmonary Disorders 
    Hepato-cardiac disorders are defined as a liver disease affecting the heart or the heart disease affecting the liver or the condition affecting heart and liver at the same time. During the Differential diagnosis of liver injury or disease, in a cardiologist, clinical practice, ask for collaboration between the hepatologists and cardiologists. In patients with advanced liver disease may show and various abnormalities like some diastolic and systolic dysfunctions, reduced cardiac performance. Cardiac evaluation in liver disease patients is important, after liver transplantation may improve cardiac function or have a reversal effect. Systemic disease with effect liver and heart are congenital, inflammatory and metabolic and alcoholism. The Hepato-pulmonary disorder which causes low oxygen levels in your blood is associated due to the formation of microscopic intrapulmonary arteriovenous dilations occurring in patients with liver cirrhosis. The mechanism is obscure due to increased hepatic production or decreased hepatic clearance of vasodilators. Due to the over perfusion related to ventilation, causes vascular dilations especially in increased cardiac yield individuals with resulting from systemic vasodilation and people having low oxygen levels in the blood encounter shortness of breath, which can become more severe over time. 
    Sub Tracks: 
     Ischemic hepatitis
     Fatty liver
     Liver cirrhosis  
    Heart failure 
    Relevant societies: 
    European society of Neuogastroenterology and Motility
    United European Gastroenterology 
     Canadian Association of Gastroenterology (CAG)
    Endoscopy and Nutrition 
     Hepato Nephrology and Hepatic Pathology 
    Liver pathology is altered in HRS while kidney histology is normal. It is a trichrome stain (chicken wire appearance) cirrhosis of the liver, the most common cause of HRS. The diagnosis of hepatorenal syndrome is based on laboratory tests of individuals susceptible to the condition. Hepatorenal syndrome (often abbreviated HRS) is a life-threatening medical condition that consists of rapid deterioration in kidney function in individuals with cirrhosis or fulminant liver failure. HRS is usually fatal unless a liver transplant is performed, although various treatments, such as dialysis, can prevent the advancement of the condition HRS can affect individuals with cirrhosis, severe alcoholic hepatitis, or liver failure, and usually occurs when liver function deteriorates rapidly because of a sudden insult such as an infection, bleeding in the gastrointestinal tract, or overuse of diuretic medications. 
    Sub Tracks: 
    Biopsy needle 
    Kidney biopsy 
    Ultrasound 
    Relevant societies: 
    Association of Gastroenterologists of Bosnia and Herzegovina
    United European Gastroenterology 
     Canadian Association of Gastroenterology (CAG)
     European Association for Gastroenterology, Endoscopy, and Nutrition
     Hepatitis and its Types 
    Hepatitis is an inflammation of the liver. The condition can be self-limiting or can progress to fibrosis (scarring), cirrhosis or liver cancer. Hepatitis viruses are the most common cause of hepatitis in the world but other infections, toxic substances (e.g. alcohol, certain drugs), and autoimmune diseases can also cause hepatitis. There are 5 main hepatitis viruses, referred to as types Hepatitis A (HAV), Hepatitis B (HBV), Hepatitis C (HCV), Hepatitis D (HDV) and Hepatitis E (HEV). These 5 types are of greatest concern because of the burden of illness and death they cause and the potential for outbreaks and epidemic spread. In particular, types B and C lead to chronic disease in hundreds of millions of people and, together, are the most common cause of liver cirrhosis and cancer. 
    Sub Tracks: 
    Autoimmune hepatitis 
    Alcoholic hepatitis 
    Viral Hepatitis 
    Granulomatous hepatitis 
    Relevant societies: 
    The Japanese Gastroenterological Association (JGA) 
    Association of Gastroenterologists of Bosnia and Herzegovina 
    Liver Biopsy 
    A liver biopsy is a procedure in which a small needle is inserted into the liver to collect a tissue sample. This is performed as an office or outpatient procedure or during surgery. The tissue is then analyzed in a laboratory to help doctors diagnose a variety of diseases and disorders in the liver. In most instances, there are no complications in obtaining a liver biopsy. However, rarely internal bleeding may occur, as well as a leak of bile from the liver or gallbladder. 
    Sub Tracks: 
    Percutaneous liver biopsy 
     Laparoscopic liver biopsy
    Relevant societies: 
    European Crohns and Colitis Organization
    Gastroenterohepatology Association of Montenegro – GAM
    Gastric and Oesophageal Surgery Association (ANZGOSA)
    Asian Pacific Association of Gastroenterology (APAGE)
    Ukrainian Association of Endoscopy 
    Stem Cell Treatment 
    Cell therapy is an emerging approach being tested in this setting. Hepatocytes are the principal cells of the liver parenchyma and are responsible for maintaining liver function. They can originate from three sources. In a normal liver, hepatocytes themselves can proliferate to restore the functional liver mass, a mechanism that could be compromised in cirrhosis. Second, the liver contains liver progenitor cells that can also proliferate and differentiate into hepatocytes. However, in some circumstances, this differentiation does not occur. Finally, blood-derived stem cells can infiltrate the liver and become hepatocytes, although the participation of this process in liver regeneration is poorly understood. Chronic liver diseases can lead to cirrhosis, characterized by fibrous septa dissecting the liver parenchyma, affecting both liver function (due to reduced functional mass) and normal intrahepatic venous pressure (due to increased stiffness). Antiviral treatment for hepatitis B or C virus infection, alcohol abstinence for alcohol-related liver disease, or weight loss strategies for metabolic non-alcoholic fatty liver disease, whereas other causes remain difficult to treat (like genetic disorders or autoimmune problems). Despite existing strategies, some patients still progress towards end-stage liver disease and its associated complications, including ascites, peritonitis, variceal bleeding, or hepatocellular carcinoma. No treatment is available to specifically target fibrosis and cirrhosis, and liver transplantation remains the only curative option. To avoid progression towards end-stage liver disease ultimately requiring rescue transplantation—which is not devoid of disadvantages (donor organ shortage, challenging surgery, and lifelong immunosuppression)—many researchers are investigating strategies to restore liver functionality. 
    Sub Tracks: 
     Differentiation of Hepatocytes
    Biochemistry in Liver Development 
     Transplantation of Cells 
    Relevant societies: 
    Major Gastroenterology Societies around the Globe
    Gastroenterological Society of Australia 
    European Society of Gastrointestinal Endoscopy (ESGE)
     European Society for Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN)
    Pediatric and Geriatric Hepatology 
    Liver diseases are mostly seen in a grown-up, however, a huge number of children from babies to teens experience from different types of liver diseases. The volume of the liver and the blood flow decreases with age, immune responses against pathogens or neoplastic cells are lower in the elderly reducing their tolerability to treatments for liver diseases. Liver regeneration capacity shows a decline in age, reduced proliferation of hepatocytes, but the level of hepatic enzymes and high-density lipoprotein cholesterol is well maintained. Pediatric hepatology focuses on the diagnosis and treatment of liver and liver-related disease in children. 
    Sub Tracks: 
    Acute Liver injury and Liver Regeneration
    Liver fibrosis
    Auto Immune Hepatitis 
    Relevant societies: 
    European society of Neuogastroenterology and Motility 
    United European Gastroenterology
    European Association for Gastroenterology 
    Endoscopy and Nutrition  
    The Japanese Gastroenterological Association (JGA)
    Obesity or Bariatric Surgery 
    Obesity has become a global health problem that contributes to numerous life-threatening and disabling diseases, such as type 2 diabetes mellitus and coronary artery disease. Bariatric surgery (weight loss surgery) is the technique used to treat obese person. The U.S. National Institutes of Health prescribes bariatric surgery for corpulent individuals with a body mass record (BMI) of no less than 40, and for individuals with BMI of no less than 35 and genuine coinciding therapeutic conditions. 
    Sub Tracks: 
     Bariatric surgery
    Eating-related behaviors
     Dietary supplements 
    Relevant societies: 
    IGA - Israel Gastroenterology Association 
    Association of Gastroenterologists of Bosnia and Herzegovina 
     Canadian Association of Gastroenterology (CAG) 
    European Association for Gastroenterology 
    Endoscopy and Nutrition
    Intestinal Rehabilitation 
    Intestinal Rehabilitation deals with the process of restoring enteral autonomy and thus allowing freedom from parenteral nutrition usually by means of dietary, medical and occasionally surgical strategies. Intestinal rehabilitation occurs as a consequence of enhanced bowel adaptation or short bowel syndrome. A coordinated team of gastroenterologists, surgeons and nutritionists provide long-term care to Patients with short or malformed intestines. 
    Sub Tracks: 
     Stroke 
     Hip fracture
    Hospital-associated deconditioning 
    Sarcopenic dysphagia 
    Relevant societies: 
     IGA - Israel Gastroenterology Association 
    Association of Gastroenterologists of Bosnia and Herzegovina
    Treatment Advances in Digestive Diseases 
    Helicobacter pylori (H. pylori) infection is a typical infection which will raise the peptic ulcers disease and gastric cancer. Most people with H. pylori infection will not have any signs and symptoms. Diagnosis can be done using blood test, breath test, stool test, scope test. Treatment can be done using Proton pump inhibitors, Histamine (H-2) blockers, Bismuth subsalicylate. Non-steroidal anti-inflammatory drugs (NSAIDs) are most widely used drugs and their widespread use is associated with increased gastro-intestinal toxic effects such as ulceration, haemorrhage, perforation and death. 
    Sub Tracks: 
    Body mass index
    Digestive function
     Eating pattern
    Sasang typology
     Type-specific pathophysiological symptoms 
    Relevant societies: 
    European Crohns and Colitis Organization 
    Gastroenterohepatology Association of Montenegro – GAM 
    The Australian and New Zealand Gastric and Oesophageal Surgery Association (ANZGOSA) 
    Asian Pacific Association of Gastroenterology (APAGE)
     Ukrainian Association of Endoscopy 
    Gastrointestinal Oncology 
    Digestive cancers can have wide-ranging effects on nutritional status, health, and quality of life. It shows the symptoms of internal bleeding, acute pains, swelling, inability to digest, difficulty in swallowing or chronic constipation or acute diarrhea. The diagnosis often requires endoscopy, pursued by biopsy of doubtful tissue. The treatment depends upon the tumour location, as well as the type of cancer cell and whether it has invaded other tissues or spread elsewhere, these factors also determine the prognosis. Esophageal cancer is the 6th common cancer in the world, and its number is increasing. 
    Sub Tracks: 
    Sarcopenia 
    Adenocarcinoma 
     Complications, Survival 
    Relevant societies: 
    Gastroenterological Society of Australia 
    British society of Gastroenterology 
    European Society of Gastrointestinal Endoscopy (ESGE)
     European Society for Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) 
    Diabetic Ketoacidosis 
    It is a life threatening problem and needs awareness about its prevention. It occurs when body doesn’t produce enough insulin and body cells can’t use sugar in blood for energy then body start using fat as fuel for energy. When the body continue to burn fat, it makes acids called ketones. If this process remains continue for a period of time, it will build up in body and can change the chemical balance of body and will affect the whole body functions. It is seen more in young ones having type 1diabetes. 
    Sub Tracks: 
    Diabetes 
    Insulin
    Rehydration
    Hypoglycemia
    Hypokalemia
    Metabolic acidosis
    Protocol 
    Relevant societies:
    European society of Neuogastroenterology and Motility
    United European Gastroenterology
    Canadian Association of Gastroenterology (CAG)
    European Association for Gastroenterology
    Endoscopy and Nutrition
     The Japanese Gastroenterological Association (JGA)
     Gastrointestinal Endoscopy 
    Gastrointestinal endoscopy is a technique that enables your specialist to take a gander at within covering of your throat your stomach, and the initial segment of your small digestive tract. A thin, adaptable review apparatus called an endoscope (scope) is utilized. The tip of the extension is embedded through your mouth and after that tenderly moved down your throat into the throat, stomach and duodenum (upper gastrointestinal tract). In patients with OGIB, upper and lower GI tract endoscopies regularly are rehashed before little gut assessment because significant starting endoscopic miss rates have been accounted for. 
     Sub Tracks: 
    Clinical endoscopy
    Demonstrative Endoscopy
    Colonoscopy and Sigmoidoscopy 
    Endoscopic Methods
    Advances in Endoscopy
    Liver Cirrhosis
    Relevant societies: 
    European society of Neuogastroenterology and Motility 
    United European Gastroenterology 
    European Association for Gastroenterology 
    Endoscopy and Nutrition
     The Japanese Gastroenterological Association (JGA)
    Inflammatory Bowel Disease 
    Inflammatory bowel disease (IBD) represents a group of intestinal disorders that cause prolonged inflammation of the digestive tract. The digestive tract comprises the mouth, oesophagus, stomach, small intestine, and large intestine. It’s responsible for breaking down food, extracting the nutrients, and removing any unusable material and waste products. Inflammation anywhere along the digestive tract disrupts this normal process. IBD can be very painful and disruptive, and in some cases, it may even be life-threatening. 
    Sub Tracks: 
     Health literacy 
     Inflammatory bowel disease
     Knowledge translation
     Ulcerative colitis 
    Relevant societies: 
    European society of Neuogastroenterology and Motility
    United European Gastroenterology
    Canadian Association of Gastroenterology (CAG)
    Endoscopy and Nutrition 
     The Japanese Gastroenterological Association (JGA) 
    Colorectal Diseases (CRD) 
    Varies from benign lesions to malignant and cancerous masses. Several tests and procedures to screen and diagnose colorectal disease, including one or more of the following Colonoscopy, flexible Sigmoidoscopy, Endoscopic ultrasound, Capsule endoscopy. Various medical and surgical treatment options for colorectal disease, including: Endoscopic mucosal resection, fecal micro biota transplant, Bowel resection, J-pouch surgery. Sub Tracks: 
    Early detection of cancer 
     Colorectal neoplasms 
     Colonoscopy 
     Computed tomographic colonography 
    Relevant societies: 
    European Crohns and Colitis Organization 
    Gastroenterohepatology Association of Montenegro – GAM 
    The Australian and New Zealand Gastric and Oesophageal Surgery Association (ANZGOSA) 
    Asian Pacific Association of Gastroenterology (APAGE) 
     Ukrainian Association of Endoscopy